Evaluation of Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act

3 organizations filed 3 public comments on Evaluation of Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act, at the Food and Drug Administration. The comment window closed 2986d ago.

Commenters (3)

• American Medical Associationtrade assoc.

  1 filing · confidence 97%
• Association for Accessible Medicinestrade assoc.

  1 filing · confidence 97%
• National Community Pharmacists Associationtrade assoc.

  1 filing · confidence 97%